Real-time enrollment status for this triple negative breast cancer (tnbc) clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 7:55 AM UTC
| NCT Number | NCT07743190 |
| Recruiting Status | Recruiting |
| Condition | Triple Negative Breast Cancer (TNBC) |
| Phase | PHASE2 |
| Target Enrollment | 55 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Medical University of South Carolina |
| Last Updated on CT.gov | August 24, 2026 (1 week ago) |
As of September 1, 2026: Clinical trial NCT07743190 is currently recruiting participants. This phase2 study for triple negative breast cancer (tnbc) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Medical University of South Carolina. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07743190 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07743190 was last updated 1 week ago (August 24, 2026). HelloStudys verifies this status automatically.